Literature DB >> 15238498

Clostridium difficile-associated diarrhea in adults.

Susan M Poutanen1, Andrew E Simor.   

Abstract

Clostridium difficile is the most important cause of nosocomial diarrhea in adults. Illness may range from mild watery diarrhea to life-threatening colitis. An antecedent disruption of the normal colonic flora followed by exposure to a toxigenic strain of C. difficile are necessary first steps in the pathogenesis of disease. Diagnosis is based primarily on the detection of C. difficile toxin A or toxin B. First-line treatment is with oral metronidazole therapy. Treatment with oral vancomycin therapy should be reserved for patients who have contraindications or intolerance to metronidazole or who fail to respond to first-line therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15238498      PMCID: PMC437686          DOI: 10.1503/cmaj.1031189

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  106 in total

1.  Molecular epidemiology of endemic Clostridium difficile infection.

Authors:  W N Fawley; M H Wilcox
Journal:  Epidemiol Infect       Date:  2001-06       Impact factor: 2.451

2.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 3.  Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature.

Authors:  Anucha Apisarnthanarak; Behzad Razavi; Linda M Mundy
Journal:  Clin Infect Dis       Date:  2002-08-26       Impact factor: 9.079

4.  Epidemiology of community-acquired Clostridium difficile-associated diarrhea.

Authors:  L R Hirschhorn; Y Trnka; A Onderdonk; M L Lee; R Platt
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

5.  Risk factors for Clostridium difficile infection.

Authors:  G E Bignardi
Journal:  J Hosp Infect       Date:  1998-09       Impact factor: 3.926

6.  Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection.

Authors:  C R Clabots; S Johnson; M M Olson; L R Peterson; D N Gerding
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

7.  Epidemiology of Clostridium difficile in infants.

Authors:  H E Larson; F E Barclay; P Honour; I D Hill
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

Review 8.  Pathogenesis of Clostridium difficile infection.

Authors:  S P Borriello
Journal:  J Antimicrob Chemother       Date:  1998-05       Impact factor: 5.790

9.  The diagnosis of Clostridium difficile-associated diarrhea: comparison of Triage C. difficile panel, EIA for Tox A/B and cytotoxin assays.

Authors:  M J Alfa; B Swan; B VanDekerkhove; P Pang; G K M Harding
Journal:  Diagn Microbiol Infect Dis       Date:  2002-08       Impact factor: 2.803

10.  Clostridium difficile colitis: an efficient clinical approach to diagnosis.

Authors:  Y C Manabe; J M Vinetz; R D Moore; C Merz; P Charache; J G Bartlett
Journal:  Ann Intern Med       Date:  1995-12-01       Impact factor: 25.391

View more
  108 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

2.  Clostridium difficile: a formidable foe.

Authors:  Vivian G Loo; Michael D Libman; Mark A Miller; Anne-Marie Bourgault; Charles H Frenette; Mirabelle Kelly; Sophie Michaud; Tuyen Nguyen; Louise Poirier; Anne Vibien; Ruth Horn; Pierre J Laflamme; Pierre René
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

3.  Successful use of nitazoxanide in the treatment of recurrent Clostridium difficile infection.

Authors:  Fnu Rafiullah; Sunil Kanwal; Usman M Majeed; Mark A Korsten; Faisal H Cheema; Munish Luthra; Muhammad Rizwan Sohail
Journal:  BMJ Case Rep       Date:  2011-11-21

4.  Evolving Strategies to Manage Clostridium difficile Colitis.

Authors:  Jessica A Bowman; Garth H Utter
Journal:  J Gastrointest Surg       Date:  2019-11-25       Impact factor: 3.452

5.  Are broad-spectrum fluoroquinolones more likely to cause Clostridium difficile-associated disease?

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Andrew E Simor; Alex Kopp; Paula A Rochon; David N Juurlink
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  Treating C. difficile.

Authors:  Bradley C Johnston; Sunita Vohra
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

7.  Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.

Authors:  Michelle M Nerandzic; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

8.  A novel subtyping assay for detection of Clostridium difficile virulence genes.

Authors:  Stephanie L Angione; Aartik A Sarma; Aleksey Novikov; Leah Seward; Jennifer H Fieber; Leonard A Mermel; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2014-01-13       Impact factor: 5.568

9.  Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile.

Authors:  Wing Huen A Chow; Cindy McCloskey; Yanhong Tong; Lin Hu; Qimin You; Ciarán P Kelly; Huimin Kong; Yi-Wei Tang; Wen Tang
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

10.  Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

Authors:  Jacques Pépin; Louis Valiquette; Marie-Eve Alary; Philippe Villemure; Annick Pelletier; Karine Forget; Karine Pépin; Daniel Chouinard
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.